The five best performing and worst performing stocks in the S&P 500 in the previous quarter pretty much tells the tale of the tape, so here goes.
Now that the service economy is pretty much stopped in its tracks, here are promising areas, including technology as manufacturing, to consider.
I don't think it would be too much of a stretch to imagine that too many investors, or citizens for that matter, will mind seeing March 2020 head on out of here.
While Johnson & Johnson and other pharma cos. give us hope, here's my wish list to keep the nation safe and the economy ready to go again.
DropBox and BioDelivery Sciences are names to consider during the market choppiness of the coming weeks.
The healthcare giant's charts still show some signs of weakness but also indicate it could rally and make a base from a higher level.
I continue to shuttle new money into the market on declines using buy-write option strategies.
We looked at the charts of REGN yesterday but with things (read: stock prices) changing so fast it wouldn't hurt to look again.
I am pretty well covered in my 'virus group'. I could definitely see bringing a few shares of REGN on board the next time the algorithms include that name in a broad selloff. Not before.
The biopharma giant's work on a coronavirus antibody treatment is helping move its shares in a different direction than the market has taken.